Invention Grant
- Patent Title: Aβ conformer selective anti-Aβ globulomer monoclonal antibodies
-
Application No.: US15155739Application Date: 2016-05-16
-
Publication No.: US09951125B2Publication Date: 2018-04-24
- Inventor: Stefan Barghorn , Heinz Hillen , Andreas R. Striebinger , Boris Labkovsky , Ulrich Ebert , Patrick Keller
- Applicant: ABBVIE INC. , ABBVIE DEUTSCHLAND GMBH & CO. KG
- Applicant Address: US IL North Chicago DE Wiesbaden
- Assignee: ABBVIE INC.,ABBVIE DEUTSCHLAND GMBH & CO. KG
- Current Assignee: ABBVIE INC.,ABBVIE DEUTSCHLAND GMBH & CO. KG
- Current Assignee Address: US IL North Chicago DE Wiesbaden
- Agency: Neal, Gerber & Eisenberg LLP
- Main IPC: C07K16/18
- IPC: C07K16/18 ; G01N33/68
Abstract:
The subject invention relates to monoclonal antibodies that may be used in the treatment and diagnosis of Alzheimer's Disease. In particular, the present invention relates to monoclonal antibodies referred to as 10F4 and 3C5 and to other monoclonal antibodies (e.g., murine, human or humanized) having similar properties thereto.
Public/Granted literature
- US20160326238A1 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES Public/Granted day:2016-11-10
Information query
